Rating History for Viracta Therapeutics (VIRX) by Rodman & Renshaw

More Stocks Rated by Rodman & Renshaw | Latest Ratings for VIRX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/27/2024 N/A Downgrade Neutral
(Buy)		 0.25
(3.50)		 0.24
(0.08)		 -66.67% Details